Log in
Create new account
home
boards
job center
archives
company monitor
cp wire
device news
pharmagather
advertise
contact us
Home
»
companies
Astellas
Abiraterone vs. MDV3100: A prostate cancer drug showdown
Abiraterone vs. MDV3100: A prostate cancer drug showdown
Fierce Biotech
abiraterone
Astellas
dimebon
MDV3100
Medivation
Pfizer
prostate cancer
MDV3100 in New Phase II Study
MDV3100 in New Phase II Study
Yahoo/Zacks
Astellas
AstraZeneca
Casodex
MDV3100
Medivation
prostate cancer
News
Comparing Medivation, Inc.'s and Johnson & Johnson's Prostate Cancer Drugs
Seeking Alpha
abiraterone
Astellas
JNJ
MDV3100
Medivation
Pfizer
prostate cancer
News
Astellas, Partners Reach Settlement With Teva on Tarceva Patent
Bloomberg
Astellas
patents
Tarceva
Teva Pharmaceuticals
Submitted by
admin
on Sat, 02/19/2011 - 13:07
Device News
Astellas, AVEO Pharma enter worldwide pact to develop & commercialize tivozanib outside of Asia
Pharmabiz
Astellas
Aveo Pharmaceutical
News
Aveo Pharma, Astellas in $1.3B cancer drug deal
Yahoo/AP
Astellas
Aveo Pharmaceutical
cancer
ONYX Pharmaceuticals
Pfizer
tivozanib
News
Optimer lands $224M licensing pact for promising antibiotic
Fierce Biotech
antibiotics
Astellas
fidaxomicin
Optimer
News
Roche’s Tarceva Extends Lives, Study Stopped Early
Bloomberg
Astellas
lung cancer
Roche
Tarceva
News
Japan's Astellas Pharma investing $10M in Cytori
Yahoo/AP
Astellas
Cytori
News
Aveo's Coming Out Party
Minyanville
Astellas
Aveo Pharmaceutical
OSI Pharmaceuticals
« first
‹ previous
…
3
4
5
6
7
8
9
10
11
…
next ›
last »
news tags
Abbott Laboratories
Amgen
Arena Pharmaceuticals
AstraZeneca
Bayer
Biogen Idec
biotech
Boston Scientific
Bristol-Myers Squibb
cancer
Celgene
China
Dendreon
diabetes
earnings
Eli Lilly
Europe
FDA
generics
Genzyme
GSK
hepatitis C
investors
JNJ
lawsuits
layoffs
M&A
Management
Medtronic
Merck
Novartis
obesity
patents
Pfizer
prostate cancer
Roche
Sanofi
Teva Pharmaceuticals
vaccines
Vivus
more tags
Yahoo! Finance
Quote for ABT